Irena Adkins
Director Pharmacology SOTIO Biotech
Irena Adkins is an immuno-Oncology scientist with a proven publication record and over 10 years of experience leading scientific and drug development teams across all stages, from drug discovery to candidate selection, IND/CTA-enabling studies, and regulatory submissions. Skilled in multifunctional program integration and providing translational research support during early clinical phases. Specializing in cytokine/ immunocytokines, ADCs and antibody-based therapies in oncology. Experienced senior leader and member of the Research Review Committee, contributing to strategic evaluation, business development, and intellectual property initiatives. Actively engaged in teaching at the 2nd Faculty of Medicine, Charles University, and University Hospital Motol, Prague.
Seminars
- Assessing preclinical combination thesis: What are the best agents to combine with ADCs?
- Breaking down preclinical investigation and use of models to understand ADC combination mechanism and rationale
- Contextualising the landscape and future perspectives of ADC-therapeutic agent combinations
